Snapshot: March Highlights
Executive Summary
A selection of articles you may have missed from March 2023, including discussion of the benefits and risks of both CAR-T and NK cell therapies, insights into how companies can source financing when VC cash is scarce, and a highlight on Pfizer's mammoth purchase of Seagen.
You may also be interested in...
Q&A: The “Secret Sauce” Of Sofinnova’s New AI-Based Investment Platform
The venture group has debuted Sofinova.AI, a software platform capable of viewing a potential investment in much more detail than a human.
Medtronic Is Not Going With The EOFlow – Deal Cancelled
Medtronic is dropping plans to acquire EOFlow, which has faced numerous patent lawsuits from Insulet.
Seeing The Wood From The Shrubs: Azalea Begins Tests Of Its Smart Contact Lens
The Belgian start-up is developing a scleral contact lens with an inbuilt LCD screen capable of filtering light – offering a non-surgical solution to a variety of ophthalmic conditions.